STEP stands for Semaglutide Treatment Effect in People with Obesity and is an ongoing program initiated by Novo Nordisk that consists of several studies (STEP 1-10, STEP TEENS, STEP UP, etc.) investigating the effect of semaglutide 2.4mg/weekly on chronic weight management [14]
Weight loss injections of this kind are well established, and the NHS recognises semaglutide within specialist weight management care, supported by NICE guidance
Importance of Personalized Care: Decisions about using semaglutide should be made on a case-by-case basis, considering the individuals health needs and cancer history
It helps manage blood sugar and inflammation, gradually slowing kidney damage
Give us a call at 704-282-9355 or schedule an appointment online here
Saeed W, Aasim SA, Qureshi MA, et al